Trials / Completed
CompletedNCT00082199
Study of Aripiprazole in Subjects With Alcoholism
A Randomized, Multicenter, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Aripiprazole in the Maintenance of Abstinence From Alcohol in Subjects With Alcoholism
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 400 (planned)
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical research study is to learn whether subjects treated with aripiprazole are able to abstain from alcohol use for a greater number of days than subjects treated with placebo. The safety of using aripiprazole will also be studied.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aripiprazole | Tablets, Oral, 2-30mg, Once daily, 12 weeks. |
| DRUG | Placebo | Tablets, Oral, Once daily, 12 weeks. |
Timeline
- Start date
- 2004-04-01
- Primary completion
- 2005-08-01
- Completion
- 2005-08-01
- First posted
- 2004-05-04
- Last updated
- 2013-11-11
Locations
14 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00082199. Inclusion in this directory is not an endorsement.